Showing 21 - 40 results of 112,518 for search '(( 12 we decrease ) OR ( 5 ((((teer decrease) OR (greater decrease))) OR (a decrease)) ))', query time: 1.46s Refine Results
  1. 21
  2. 22

    The Immunologic Effects of Mesalamine in Treated HIV-Infected Individuals with Incomplete CD4+ T Cell Recovery: A Randomized Crossover Trial by Ma Somsouk (283498)

    Published 2014
    “…The effect of mesalamine in HIV-infected individuals, who exhibit abnormal mucosal immune activation and microbial translocation (MT), has not been established in a placebo-controlled trial. We randomized 33 HIV-infected subjects with CD4 counts <350 cells/mm<sup>3</sup> and plasma HIV RNA levels <40 copies/ml on antiretroviral therapy (ART) to add mesalamine vs. placebo to their existing regimen for 12 weeks followed by a 12 week crossover to the other arm. …”
  3. 23
  4. 24
  5. 25
  6. 26
  7. 27
  8. 28

    Table_1_The Increase in Paraoxonase 1 Is Associated With Decrease in Left Ventricular Volume in Kidney Transplant Recipients.docx by Philip W. Connelly (10522333)

    Published 2021
    “…Restored kidney function through transplantation reduces left ventricular volume in both systole and diastole. We previously reported that the decrease in NT-proB-type natriuretic peptide (NT-proBNP) was associated with a decrease in adiponectin. …”
  9. 29
  10. 30
  11. 31
  12. 32
  13. 33
  14. 34
  15. 35
  16. 36
  17. 37

    24 hours of ARD results in noticeable decrease in ORO staining. by Moriah Eustice (13813098)

    Published 2022
    “…<p>(A) Decrease in ORO signal were observable at 24 hr after worms were placed on ARD plates (as compared to control fed worms in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0274076#pone.0274076.g005" target="_blank">Fig 5</a>), as shown with representative strains. …”
  18. 38

    Supplementary Material for: Decreased Systemic Levels of Endocan-1 and CXCL16 in Psoriasis Are Restored following Narrowband UVB Treatment by Sigurdardottir G. (5710955)

    Published 2018
    “…<b><i>Results:</i></b> We identified the mediators endocan-1, CXCL16, and sVEGFR1, which were systemically decreased in psoriasis at baseline, as well as FABP3, FABP4, and sIL-1R1, which showed normal baseline levels. …”
  19. 39
  20. 40